Table 2 Comparison among inhibition zones of nanoparticles and antibiotics against clinical strains.
Sr No. | Clinical Strains | Zone of inhibition in mm | |||||
|---|---|---|---|---|---|---|---|
Antibiotics | Zone | Cassia fistula | Melia azadarach | ||||
ZnO NPs | ZnO NPs | ||||||
10 µl | 200 µl | 10 µl | 200 µl | ||||
1. | E. coli | Ceftazidime | 20 ± 0.04 | 21 ± 0.068 | 44 ± 0.300 | 20 ± 0.56 | 40 ± 0.48 |
Imipenem | 22 ± 0.02 | ||||||
Cefoperazone | 19 ± 0.21 | ||||||
Amoxicillin | 18 ± 0.09 | ||||||
Amikacin | 15 ± 0.085 | ||||||
Ceftriaxone | 16 ± 0.16 | ||||||
Tobramycin | 17 ± 0.17 | ||||||
Levoflaxin | 18 ± 0.11 | ||||||
Tazobactum | 18 ± 0.07 | ||||||
2. | S. aureus | Erythromycin | R | 14 ± 0.054 | 32 ± 0.230 | 21 ± 0.68 | 38 ± 0.55 |
Gentamycin | 4 ± 0.45 | ||||||
Vancomycin | 5 ± 0.32 | ||||||
Chloramphenicol | 12 ± 0.05 | ||||||
Cefoxitin | R | ||||||
Clindamycin | R | ||||||
Co trimonazole | R | ||||||
Ciprofloxacin | R | ||||||
